Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-035872
Date:2022-06-08
Issuer: LYELL IMMUNOPHARMA, INC. (LYEL)
Original Submission Date:

Reporting Person:

NELSEN ROBERT
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-06-08 0 $0.00 18,206,358 indirect f1
COMMON STOCK 2022-06-08 0 $0.00 18,206,358 indirect f2
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION (RIGHT TO BUY) 5.31 2022-06-08 deemed execution date A 65,000 (a) 2032-06-07 common stock 65,000 $5.31 65,000 direct
Footnotes
IDfootnote
f1 these shares are directly held by arch venture fund ix, l.p. ("avf ix") (the "avf ix shares"). arch venture partners ix, l.p. ("avp ix lp"), as the sole general partner of avf ix, may be deemed to beneficially own the avf ix shares. arch venture partners ix, llc ("avp ix llc"), as the sole general partner of avp ix lp, may be deemed to beneficially own the avf ix shares. as a managing director of avp ix llc, the reporting person may also be deemed to share the power to direct the disposition and vote of the avf ix shares. avp ix lp, avp ix llc and the reporting person each disclaim beneficial ownership of the avf ix shares except to the extent of any pecuniary interest therein.
f2 these shares are directly held by arch venture fund ix overage, l.p. ("avf ix overage") (the "avf ix overage shares"). arch venture partners ix overage, l.p. ("avp ix overage lp"), as the sole general partner of arch ix overage, may be deemed to beneficially own the avf ix overage shares. avp ix llc, as the sole general partner of avp ix overage lp, may be deemed to beneficially own the avf ix overage shares. as a managing director of avp ix llc, the reporting person may also be deemed to share the power to direct the disposition and vote of the avf ix overage shares. avp ix overage lp, avp ix llc and the reporting person each disclaim beneficial ownership of the avf overage shares except to the extent of any pecuniary interest therein.
f3 the option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following june 8, 2022 (or the date immediately prior to such date if the reporting person's service as a director ends at such annual meeting due to the reporting person's failure to be reelected or the reporting person not standing for re-election); or (b) the first anniversary of june 8, 2022, subject to the reporting person providing continuous service through such date.
WhaleWisdom Logo

Elevate your investments